Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Richard Wilson

8PUBLICATIONS

79CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersSolid tumoursCounselling psychologyCancer genetics

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|Nov 25, 2025

MAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistance.

Mark White, Megan L Mills, Laura M Millett

|Mar 21, 2024

Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis: the EASI-SWITCH RCT.

Vicky Coyle, Caroline Forde, Richard Adams

|Jul 07, 2023

Thromboxane biosynthesis in cancer patients and its inhibition by aspirin: a sub-study of the Add-Aspirin trial.

Nalinie Joharatnam-Hogan, Duaa Hatem, Fay H Cafferty

|May 14, 2022

A first-in-human Phase I dose-escalation trial of the novel therapeutic peptide, ALM201, demonstrates a favourable safety profile in unselected patients with ovarian cancer and other advanced solid tumours.

Aya El Helali, Ruth Plummer, Gordon C Jayson

|Feb 22, 2022

Reply to A. Kurreck et al and M.S. Copur et al.

Richard Adams, Richard Wilson, Louise Brown

|Jan 27, 2022

Experiences of running a stratified medicine adaptive platform trial: Challenges and lessons learned from 10 years of the FOCUS4 trial in metastatic colorectal cancer.

Louise C Brown, Janet Graham, David Fisher

Pageof 2

Frequent Collaborators

5 joint publications

Richard Adams

4 joint publications

Louise C Brown

3 joint publications

Richard Kaplan

3 joint publications

Timothy S Maughan

2 joint publications

David J Fisher

2 joint publications

Jenny F Seligmann

2 joint publications

Matthew Seymour

2 joint publications

Mahesh Parmar

2 joint publications

Philip Quirke

2 joint publications

Ewan Brown

Frequent Collaborators

5 joint publications

Richard Adams

4 joint publications

Louise C Brown

3 joint publications

Richard Kaplan

3 joint publications

Timothy S Maughan

Top Related Videos

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on : Sep 30, 2016

An Ex vivo Assay to Study <em>Candida albicans</em> Hyphal Morphogenesis in the Gastrointestinal Tract

An Ex vivo Assay to Study <em>Candida albicans</em> Hyphal Morphogenesis in the Gastrointestinal Tract

Published on : Jul 01, 2020

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on : Jan 18, 2017

See more related videos

Top Related Videos

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on : Sep 30, 2016

An Ex vivo Assay to Study <em>Candida albicans</em> Hyphal Morphogenesis in the Gastrointestinal Tract

An Ex vivo Assay to Study <em>Candida albicans</em> Hyphal Morphogenesis in the Gastrointestinal Tract

Published on : Jul 01, 2020

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on : Jan 18, 2017

See more related videos